Datavault AI Creates DelivMeds AI Venture via Wellgistics Partnership and Acquisitions

May 20th, 2026 6:30 PM
By: Newsworthy Staff

Datavault AI announced a binding term sheet with Wellgistics Health to form DelivMeds AI, a healthcare platform integrating AI, blockchain, and biometrics, with an expected asset value of $4 billion.

Datavault AI Creates DelivMeds AI Venture via Wellgistics Partnership and Acquisitions

Datavault AI (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health to create DelivMeds AI, a healthcare platform that combines AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification, and direct-to-consumer healthcare delivery. The initiative involves three concurrent transactions: an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. The combined transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions.

This venture marks a significant step in integrating advanced technologies into healthcare, aiming to improve efficiency, security, and patient outcomes. By leveraging Datavault AI's expertise in AI-driven data experiences and Wellgistics Health's pharmaceutical network, DelivMeds AI could transform how prescriptions are managed and delivered. The use of blockchain for smart contracts ensures transparency and trust in transactions, while biometric verification enhances security and personalization.

The implications of this announcement are far-reaching. For the healthcare industry, DelivMeds AI represents a move towards more integrated and technology-driven solutions, potentially reducing costs and errors associated with traditional pharmacy operations. For investors, the $4 billion asset valuation underscores the market's confidence in the convergence of AI and healthcare. Additionally, the partnership may accelerate the adoption of digital health tools, particularly in the wake of increased demand for remote and contactless services.

Datavault AI's technology suite, which includes AI and machine learning automation, third-party integration, and detailed analytics, will be central to DelivMeds AI's operations. The company's Acoustic Sciences and Data Science divisions bring patented technologies in spatial audio and data valuation, which could be applied to enhance user experience and data integrity in healthcare settings.

For more details on the press release, visit https://ibn.fm/yIVh9. Information about Datavault AI can be found at www.dvlt.ai.

Source Statement

This news article relied primarily on a press release disributed by NewMediaWire. You can read the source press release here,

blockchain registration record for the source press release.
;